Oxana Palesh1,2, Karyn Haitz3, Francis Lévi4,5,6, Georg A Bjarnason7, Carl Deguzman3, Igbal Alizeh3, Ayhan Ulusakarya4, Mary Melissa Packer3,8, Pasquale F Innominato5,6. 1. Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Road, Stanford, CA, 94305, USA. opalesh@stanford.edu. 2. Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA. opalesh@stanford.edu. 3. Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Road, Stanford, CA, 94305, USA. 4. INSERM U935 and AP-HP, Chronotherapy Unit, Department of Medical Oncology, Paul Brousse Hospital, Villejuif, France. 5. Cancer Chronotherapy Unit, Cancer Research Centre, Warwick Medical School, Coventry, Warwickshire, UK. 6. Department of Oncology, Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, UK. 7. Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. 8. Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA.
Abstract
OBJECTIVE: Patients with cancers frequently experience sleep and circadian dysfunction. To date, only a few studies have used both a questionnaire and actigraphy for concomitant evaluation of sleep and circadian function in patients with cancer. We sought to evaluate objective sleep and circadian parameters in metastatic colon cancer (MCC) patients and their associations with symptoms and quality of life (QOL). METHODS: Patients reported subjective sleep problems on the EORTC QLQ-C30. Sleep and circadian parameters were calculated using a wrist-actigraph that patients wore for 72 h. RESULTS: 237 Patients with MCC (mean age: 60.4 years; range: 20.7-77.6; Male/Female ratio: 1.66) participated in this cross-sectional study. Subjective sleep problems were reported by 63.4% of patients (S+). No differences in any sleep parameters (sleep efficiency, sleep latency, total sleep time, total time in bed, wake after sleep onset, activity bathyphase) were observed between S+ and S- patients. However, S+ patients displayed a significantly worse circadian function than S- patients (96.4 vs 98.1%; p = 0.005). The presence of poor subjective sleep and objective circadian dysfunction negatively affected symptoms and QOL domains (p = 0.038). CONCLUSIONS: Subjective report of sleep problems was not associated with worse objectively measured sleep parameters in patients with MCC although it was associated with disrupted circadian rest-activity rhythm and poorer QOL. These findings coincide with prior research in cancer patients in that an inconsistent relationship exists between subjective and objective sleep measurements on some sleep domains. This study supports the value of coupled evaluation of self-reported and objective measures of sleep and circadian function in cancer patients.
OBJECTIVE:Patients with cancers frequently experience sleep and circadian dysfunction. To date, only a few studies have used both a questionnaire and actigraphy for concomitant evaluation of sleep and circadian function in patients with cancer. We sought to evaluate objective sleep and circadian parameters in metastatic colon cancer (MCC) patients and their associations with symptoms and quality of life (QOL). METHODS:Patients reported subjective sleep problems on the EORTC QLQ-C30. Sleep and circadian parameters were calculated using a wrist-actigraph that patients wore for 72 h. RESULTS: 237 Patients with MCC (mean age: 60.4 years; range: 20.7-77.6; Male/Female ratio: 1.66) participated in this cross-sectional study. Subjective sleep problems were reported by 63.4% of patients (S+). No differences in any sleep parameters (sleep efficiency, sleep latency, total sleep time, total time in bed, wake after sleep onset, activity bathyphase) were observed between S+ and S- patients. However, S+ patients displayed a significantly worse circadian function than S- patients (96.4 vs 98.1%; p = 0.005). The presence of poor subjective sleep and objective circadian dysfunction negatively affected symptoms and QOL domains (p = 0.038). CONCLUSIONS: Subjective report of sleep problems was not associated with worse objectively measured sleep parameters in patients with MCC although it was associated with disrupted circadian rest-activity rhythm and poorer QOL. These findings coincide with prior research in cancerpatients in that an inconsistent relationship exists between subjective and objective sleep measurements on some sleep domains. This study supports the value of coupled evaluation of self-reported and objective measures of sleep and circadian function in cancerpatients.
Authors: Luciane de Souza; Ana Amélia Benedito-Silva; Maria Laura Nogueira Pires; Dalva Poyares; Sergio Tufik; Helena Maria Calil Journal: Sleep Date: 2003-02-01 Impact factor: 5.849
Authors: Michael Littner; Clete A Kushida; W McDowell Anderson; Dennis Bailey; Richard B Berry; David G Davila; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Daniel Loube; Merrill Wise; Stephen F Johnson Journal: Sleep Date: 2003-05-01 Impact factor: 5.849
Authors: Pasquale F Innominato; Véronique P Roche; Oxana G Palesh; Ayhan Ulusakarya; David Spiegel; Francis A Lévi Journal: Ann Med Date: 2014-06 Impact factor: 4.709
Authors: Anand Dhruva; Steven M Paul; Bruce A Cooper; Kathryn Lee; Claudia West; Bradley E Aouizerat; Laura B Dunn; Patrick S Swift; William Wara; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2012-07-11 Impact factor: 3.612
Authors: Derek Kyte; Bryce B Reeve; Fabio Efficace; Kirstie Haywood; Rebecca Mercieca-Bebber; Madeleine T King; Josephine M Norquist; William R Lenderking; Claire Snyder; Lena Ring; Galina Velikova; Melanie Calvert Journal: Qual Life Res Date: 2015-08-15 Impact factor: 4.147
Authors: Jeongok G Logan; Hyojung Kang; Jennifer Mason Lobo; Min-Woong Sohn; Gen-Min Lin; Joao A C Lima; Naresh M Punjabi; Susan Redline; Younghoon Kwon Journal: J Am Soc Hypertens Date: 2018-09-29